PEO.DEPEO.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank71
3Y CAGR+13.2%
5Y CAGR+2.1%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+13.2%/yr
vs -9.3%/yr prior
5Y CAGR
+2.1%/yr
Recent acceleration
Acceleration
+22.5pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$9.06B+26.0%
2024$7.19B+5.6%
2023$6.81B+9.1%
2022$6.24B-36.0%
2021$9.75B+19.4%
2020$8.17B-20.8%
2019$10.31B+11.6%
2018$9.24B-10.3%
2017$10.29B+18.7%
2016$8.68B-